Clinically Significant Improvements in Genital Psoriasis Observed With Apremilast

The phase 3 DISCREET study evaluated apremilast in 289 patients with moderate to severe genital psoriasis and moderate to severe plaque psoriasis.

Related Keywords

,Global Assessment ,Genital Psoriasis Itch Numerical Rating Scale ,Genital Psoriasis Symptoms ,Dermatology Life Quality Index ,